Inogen Inc (INGN)
7.08
+0.13
(+1.87%)
USD |
NASDAQ |
Apr 18, 16:00
7.07
-0.01
(-0.14%)
After-Hours: 20:00
Inogen Cash and Short Term Investments (Quarterly): 128.47M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 128.47M |
September 30, 2023 | 138.04M |
June 30, 2023 | 170.15M |
March 31, 2023 | 174.56M |
December 31, 2022 | 187.01M |
September 30, 2022 | 209.63M |
June 30, 2022 | 223.62M |
March 31, 2022 | 223.39M |
December 31, 2021 | 245.51M |
September 30, 2021 | 245.13M |
June 30, 2021 | 249.96M |
March 31, 2021 | 233.15M |
December 31, 2020 | 231.22M |
September 30, 2020 | 220.51M |
June 30, 2020 | 218.64M |
March 31, 2020 | 208.36M |
December 31, 2019 | 209.09M |
September 30, 2019 | 200.64M |
June 30, 2019 | 256.15M |
March 31, 2019 | 239.25M |
December 31, 2018 | 240.35M |
September 30, 2018 | 223.86M |
Date | Value |
---|---|
June 30, 2018 | 208.41M |
March 31, 2018 | 188.30M |
December 31, 2017 | 173.94M |
September 30, 2017 | 163.09M |
June 30, 2017 | 144.21M |
March 31, 2017 | 128.24M |
December 31, 2016 | 113.88M |
September 30, 2016 | 108.34M |
June 30, 2016 | 98.12M |
March 31, 2016 | 86.09M |
December 31, 2015 | 82.90M |
September 30, 2015 | 74.12M |
June 30, 2015 | 66.06M |
March 31, 2015 | 61.10M |
December 31, 2014 | 56.84M |
September 30, 2014 | 56.16M |
June 30, 2014 | 69.05M |
March 31, 2014 | 59.55M |
December 31, 2013 | 13.52M |
September 30, 2013 | 17.06M |
December 31, 2012 | 15.11M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
128.47M
Minimum
Dec 2023
256.15M
Maximum
Jun 2019
209.12M
Average
218.64M
Median
Jun 2020
Cash and Short Term Investments (Quarterly) Benchmarks
Oragenics Inc | 3.484M |
Palatin Technologies Inc | 9.485M |
Oramed Pharmaceuticals Inc | 162.05M |
vTv Therapeutics Inc | 9.446M |
G1 Therapeutics Inc | 82.16M |